Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation
September 29th, 2019
5.4K views
This protocol describes a purification method for recombinant tag-free calcium binding protein S100A12 and its ion-induced oligomers for human monocyte stimulation assays.
Overview
This protocol describes a purification method for the human calcium binding protein S100A12 and its ion-induced oligomers. The technique maintains high yield of pure and endotoxin-free protein for human monocyte stimulation assays.
Key Study Components
Area of Science
- Biochemistry
- Cell Biology
- Immunology
Background
- S100A12 is a calcium binding protein involved in immune responses.
- Understanding its oligomers can provide insights into its function as a pattern recognition receptor ligand.
- Purification methods are critical for studying protein interactions and functions.
- Endotoxin-free proteins are essential for accurate biological assays.
Purpose of Study
- To develop a reliable purification protocol for S100A12.
- To generate homo-oligomeric proteins for functional assays.
- To explore the mechanistic aspects of S100A12 in immune responses.
Methods Used
- Cut dialysis tubing to an appropriate length for protein purification.
- Utilize chemical cross-linking for oligomer generation.
- Employ size exclusion chromatography for protein separation.
- Conduct downstream assays to evaluate protein function.
Main Results
- Successfully purified S100A12 with high yield and purity.
- Generated various ion-induced oligomers for functional studies.
- Demonstrated the potential of S100A12 as a target for new interventions.
- Provided a detailed protocol for reproducibility in research.
Conclusions
- The purification method is effective for obtaining S100A12 and its oligomers.
- This study enhances understanding of S100A12's role in immune responses.
- Future research can leverage this protocol for therapeutic development.
Frequently Asked Questions
What is S100A12?
S100A12 is a calcium binding protein involved in immune system regulation.
Why is endotoxin-free protein important?
Endotoxin-free proteins are crucial for accurate biological assays to avoid skewed results.
What methods are used for purification?
The protocol uses dialysis, chemical cross-linking, and size exclusion chromatography.
What are the applications of S100A12?
S100A12 can be studied for its role in immune responses and potential therapeutic targets.
How can this protocol be accessed?
The protocol is available in the JoVE video library for detailed viewing.
Executive Industry Relevance
This protocol enables the production of endotoxin-free S100A12 protein and its defined ion-induced oligomers, providing a reliable tool for mechanistic studies of pattern recognition receptor signaling in immune cells. By generating homogeneous oligomeric states, the method supports target validation and mechanistic de-risking in early discovery programs focused on inflammatory pathways. The purified protein facilitates functional assays that link structural states to biological activity, informing therapeutic intervention design and diagnostic assay development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of S100A12 oligomerization states as a mechanism for modulating immune cell activation.
- Operational Value: Provides a reproducible purification workflow yielding high-purity, endotoxin-free protein suitable for functional immune cell assays.
- Predictive Value: Supports structure-function correlation by stabilizing defined oligomers via chemical crosslinking for downstream signaling analysis.
Screening & Assay Development
- Scientific Value: Generates well-characterized S100A12 oligomers (dimer, tetramer, hexamer) as defined ligands for screening immunomodulatory compounds or antibodies.
- Operational Value: Produces protein batches with consistent oligomer profiles, enabling standardized immune stimulation assays such as TNF-alpha release in monocytes.
- Assay Readiness: Delivers endotoxin-free protein preparations critical for avoiding false-positive signals in cell-based functional readouts.
Translational & Preclinical Research
- Translational Continuity: Bridges biochemical oligomerization data with functional immune cell responses, supporting biomarker-aligned target validation.
- Preclinical Model Relevance: Enables testing of S100A12 oligomers in human monocyte systems, reflecting disease-relevant immune activation pathways.
- Mechanistic De-risking: Clarifies ion-dependent oligomerization behavior, reducing ambiguity in target mechanism prior to lead optimization.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, supporting target validation through biochemical definition of oligomeric states and their functional consequences in immune cells, thereby informing lead identification and preclinical prioritization.
- Discovery Biology: Supports hypothesis testing on ion-induced oligomerization as a regulatory mechanism for S100A12 activity in immune signaling.
- Screening: Enables production of standardized oligomeric ligands for assay development targeting S100A12-mediated pathways.
- Analytics: Utilizes size-exclusion chromatography and SDS-PAGE to resolve and quantify oligomeric species, providing measurable outputs for structure-function correlation.
- Translational Research: Connects purified oligomers to human monocyte stimulation assays, enabling evaluation of proinflammatory outputs like TNF-alpha release.
- Enterprise Reuse: Establishes a reusable purification platform for generating defined protein oligomers applicable to other calcium-binding proteins in immunomodulation research.
Operational & Enterprise Impact
- Scientific Value: Defines structure-function relationships by linking specific ion-induced oligomers to immune cell activation profiles.
- Operational Value: Delivers high-yield, endotoxin-free protein through a scalable two-step chromatography approach with validated contaminant removal steps.
- Strategic Value: Reduces mechanistic uncertainty in target validation, enabling more confident go/no-go decisions in inflammatory target programs.
- Portfolio Impact: Supports risk-adjusted advancement by providing mechanistic clarity on oligomer-specific bioactivity.
Implementation Considerations
- Expertise in protein purification techniques including ion-exchange, hydrophobic interaction, and size-exclusion chromatography.
- Access to FPLC systems, centrifugal filtration units, and equipment for chemical crosslinking and oligomer stabilization.
- Standardization of ion conditions (e.g., calcium, zinc) to reproducibly generate defined oligomeric states.
- Validation of endotoxin removal using appropriate assays (e.g., LAL test) to ensure assay compatibility.
- Adaptation considerations for applying the oligomerization strategy to other S100 family members or calcium-regulated proteins.
Biopharma FAQs
Why does endotoxin removal matter for immune cell stimulation assays?
Endotoxin contamination can trigger nonspecific immune activation, confounding results in monocyte stimulation assays; the protocol includes dialysis and centrifugal filtration steps to deplete residual endotoxin after anion-exchange chromatography, ensuring observed responses are due to S100A12 oligomers and not LPS artifacts.
How does ion-induced oligomerization affect S100A12 function in immune cells?
Different ions promote distinct oligomeric states; for example, zinc induces tetramer and hexamer formation, and monocyte stimulation with hexameric S100A12 leads to pronounced TNF-alpha release, demonstrating a direct link between oligomer structure and proinflammatory activity.
What analytical methods confirm oligomer purity and identity after purification?
Protein fractions are analyzed by Coomassie-stained SDS-PAGE (4-20% gradient) to identify pure oligomeric bands, which are then pooled and concentrated; this approach enables separation and validation of dimer, tetramer, and hexamer species following chemical crosslinking and size-exclusion chromatography.
Why is chemical crosslinking used before size-exclusion chromatography in this protocol?
Chemical crosslinking stabilizes transient ion-induced oligomers, allowing their separation by size-exclusion chromatography and preventing dissociation during analysis, thereby enabling the isolation and functional testing of defined oligomeric states such as tetramers and hexamers.
What functional output is used to validate the biological activity of purified S100A12 oligomers?
Monocyte stimulation with purified S100A12 oligomers is followed by measurement of TNF-alpha release, with hexameric S100A12 eliciting a pronounced response, providing a quantitative, biologically relevant readout of oligomer-specific immune activation.
